The combination of a tiny capital raise ($19K) and massive option grants (11M+ shares at $0.001) signals severe cash constraints and potential future dilution. Monitor for further capital raises or reverse splits. The insider participation is a modest positive signal but is overwhelmed by the dilution risk.
Price Chart
Executive Summary
IR-Med completed a private placement on May 31, 2026, raising $19,054 in gross proceeds through the sale of 250,000 shares at $0.10 per share and 250,000 warrants exercisable at $0.10 for five years. All purchasers were directors/chairman, signaling insider support. Separately, the board granted 11,056,507 fully vested options at $0.001 per share to three directors, creating massive potential dilution.
Key Financial Metrics
Key Facts
- Private placement raised $19,054 from the sale of 250,000 shares at $0.10/share with 250,000 warrants at $0.10 exercise price.
- All purchasers were directors/chairman (Oded Bashan, Yechiel Even, Ron Mayron, Aharon Klein, Yaniv Cohen, Ohad Bashan).
- Board granted 5,040,000 options to Chairman Oded Bashan, 3,236,519 to Director Aharon Klein, and 2,779,988 to Director Yaniv Cohen — all fully vested at $0.001/share, 10-year term.
- Options were granted outside the 2020 Incentive Stock Option Plan.
- The offering closed on May 31, 2026; the 8-K was filed June 3, 2026.
Financial Impact
Gross proceeds of $19,054 from equity sale; potential dilution from 11,056,507 options at $0.001/share is massive relative to the 250,000 shares sold.
Risk Factors
- Massive potential dilution from 11M+ options at near-zero exercise price.
- Tiny capital raise suggests acute cash needs; further dilutive financing likely.
- Options granted outside the 2020 plan may indicate governance concerns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-027047 |
| Exhibit: ex4-1.htm | 0001493152-26-027047 |
| Document: form8-k.htm | 0001493152-26-027047 |
| Document: 0001493152-26-027047-index-headers.html | 0001493152-26-027047 |
| Document: 0001493152-26-027047-index.html | 0001493152-26-027047 |
| Document: 0001493152-26-027047.txt | 0001493152-26-027047 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers